We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant

Delisted

TROVW was delisted on the 30th of May, 2017.

3 hedge funds and large institutions have $1.81M invested in TrovaGene, Inc. Warrant in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more capital invested

Capital invested by funds: $1.45M → $1.81M (+$360K)

25% less funds holding

Funds holding: 43 (-1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $9K

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
2
Closed
1
Calls
Puts
$9K
Net Calls
-$9K
Net Calls Change
-$9K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$1.81M -$583 -200 -0%
U
2
UBS
Switzerland
$3K +$1.22K +419 +97%
GSC
3
Ground Swell Capital
South Carolina
-$1K -390 Closed
TRCT
4
Tower Research Capital (TRC)
New York
-$225 -77 -74%

TROVW Hedge Fund Activity: Q3 2014 in Review

3 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q3 2014, worth a combined $1.81M — up 25% from $1.45M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of TROVW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was UBS, adding an estimated $1.22K. The largest seller was Ground Swell Capital, exiting entirely with an estimated $1K sold.

  • 3 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q3 2014, down from 4 in Q2 2014.
  • Funds reported $1.81M of TrovaGene, Inc. Warrant stock for Q3 2014, up 25% quarter-over-quarter.
  • 0 funds opened new TrovaGene, Inc. Warrant positions in Q3 2014 and 1 closed out, a net change of -1 holder.
  • The largest TrovaGene, Inc. Warrant buyer in Q3 2014 was UBS, an estimated $1.22K added.
  • The largest TrovaGene, Inc. Warrant seller in Q3 2014 was Ground Swell Capital, an estimated $1K sold.

Based on aggregated 13F filings for Q3 2014.